AVGR Stock: Avinger, Inc. Stock Price, Analysis & Insights
Get live avgr stock price $0.47, comprehensive Avinger, Inc. stock analysis, charts, news, and expert forecast. Real-time avgr stock data and investment insights.
Loading chart...
Company Overview
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was incorporated in 2007 and is headquartered in Redwood City, California.
Company Information
- CEO
- Nabeel P. Subainati CPA
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Employees
- 68
Contact Information
- Website
- https://avinger.com
- Address
- 400 Chesapeake Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Avinger, Inc. operates in the Medical - Instruments & Supplies industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Nabeel P. Subainati CPA, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Instruments & Supplies model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Avinger, Inc. competes in the Medical - Instruments & Supplies within the broader Healthcare. With 1.5 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Avinger, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Avinger, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Avinger, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Avinger, Inc.
- ⚠Investors should consider how Avinger, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.52M
P/E Ratio
-0.05
Beta
1.09
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 1.52M market capitalization
- Trading Volume: 2.59M shares traded today
- Price Range: 52-week range of $0.36 - $4.37
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Avinger, Inc.
Avinger, Inc. (AVGR) operates in the Medical - Instruments & Supplies industry within the Healthcare sector. With a current market capitalization of 1.52M, the company represents a significant player in its market. The stock is currently trading at $0.47 with a negativedaily change of 20.74%.
The company's 68 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.05, beta of 1.09, and 52-week price range from $0.36 to $4.37when evaluating investment opportunities.
Why Invest in Avinger, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Nabeel P. Subainati CPA
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.